161 related articles for article (PubMed ID: 35484352)
1. Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma.
Karavyraki M; Porter RK
Med Oncol; 2022 Apr; 39(5):60. PubMed ID: 35484352
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro.
Dil N; Banerjee AG
Head Neck Oncol; 2012 Jun; 4():11. PubMed ID: 22507529
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase.
Zhang Y; Lu H; Dazin P; Kapila Y
J Biol Chem; 2004 Nov; 279(46):48342-9. PubMed ID: 15331608
[TBL] [Abstract][Full Text] [Related]
5. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas.
Rydberg C; Månsson A; Uddman R; Riesbeck K; Cardell LO
Immunology; 2009 Sep; 128(1 Suppl):e600-11. PubMed ID: 19740321
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer.
Swan EA; Jasser SA; Holsinger FC; Doan D; Bucana C; Myers JN
Oral Oncol; 2003 Oct; 39(7):648-55. PubMed ID: 12907203
[TBL] [Abstract][Full Text] [Related]
8. The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.
Parra-Izquierdo I; Lakshmanan HHS; Melrose AR; Pang J; Zheng TJ; Jordan KR; Reitsma SE; McCarty OJT; Aslan JE
Front Immunol; 2021; 12():729951. PubMed ID: 34527000
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
10. Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma.
Almahmoudi R; Salem A; Sieviläinen M; Sundquist E; Almangush A; Toppila-Salmi S; Paavonen T; Salo T; Al-Samadi A
Head Neck; 2018 Oct; 40(10):2155-2165. PubMed ID: 29761594
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlation of tumor-stroma ratio and inflammatory cell infiltrate with tumor grade and lymph node metastasis in squamous cell carcinoma of buccal mucosa and tongue in 41 cases with review of literature.
Rani P; Gupta AJ; Mehrol C; Singh M; Khurana N; Passey JC
J Cancer Res Ther; 2020; 16(3):445-451. PubMed ID: 32719249
[TBL] [Abstract][Full Text] [Related]
12. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.
Dil N; Banerjee AG
Head Neck Oncol; 2011 Sep; 3():44. PubMed ID: 21958730
[TBL] [Abstract][Full Text] [Related]
13. Size of cervical lymph node and metastasis in squamous cell carcinoma of the oral tongue and floor of mouth.
Jarungroongruangchai W; Charoenpitakchai M; Silpeeyodom T; Pruksapong C; Burusapat C
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S101-6. PubMed ID: 25518182
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
15. Head and neck cancers, but not benign lesions, express interleukin-4 receptors in situ.
Mehrotra R; Varricchio F; Husain SR; Puri RK
Oncol Rep; 1998; 5(1):45-8. PubMed ID: 9458290
[TBL] [Abstract][Full Text] [Related]
16. Endothelial derived factors inhibit anoikis of head and neck cancer stem cells.
Campos MS; Neiva KG; Meyers KA; Krishnamurthy S; Nör JE
Oral Oncol; 2012 Jan; 48(1):26-32. PubMed ID: 22014666
[TBL] [Abstract][Full Text] [Related]
17. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice.
Umeda M; Yokoo S; Komori T; Nishimatsu N; Shibuya Y; Fujioka M
Br J Oral Maxillofac Surg; 2001 Oct; 39(5):376-80. PubMed ID: 11601820
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of drosomycin-like defensin in oral epithelium and oral carcinoma cell lines.
Sato J; Nishimura M; Yamazaki M; Yoshida K; Kurashige Y; Saitoh M; Abiko Y
Arch Oral Biol; 2013 Mar; 58(3):279-85. PubMed ID: 23084467
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma.
Tsimplaki E; Argyri E; Xesfyngi D; Daskalopoulou D; Stravopodis DJ; Panotopoulou E
Anticancer Res; 2014 Feb; 34(2):1021-5. PubMed ID: 24511049
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells.
Al-Eryani K; Cheng J; Abé T; Maruyama S; Yamazaki M; Babkair H; Essa A; Saku T
Hum Pathol; 2015 Jul; 46(7):991-9. PubMed ID: 25912757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
